Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Endocrine 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6874 Lung Neoplasms 5105 Small Cell Lung Carcinoma 1166 Breast Neoplasms 855 Neoplasms 762 Colorectal Neoplasms 670 Melanoma 566 Ovarian Neoplasms 506 Neoplasm Metastasis 481 Pancreatic Neoplasms 473 Adenocarcinoma of Lung 398 Stomach Neoplasms 396 Prostatic Neoplasms 370 Head and Neck Neoplasms 368 Carcinoma, Renal Cell 350 Esophageal Neoplasms 337 Squamous Cell Carcinoma of Head and Neck 325 Mesothelioma, Malignant 324 Colonic Neoplasms 294 Mesothelioma 289 Urinary Bladder Neoplasms 262 Brain Neoplasms 254 Uterine Cervical Neoplasms 243 Triple Negative Breast Neoplasms 223 Sarcoma 198 Endometrial Neoplasms 196 Carcinoma, Hepatocellular 186 NSCLC 167 Pleural Effusion, Malignant 160 Kidney Neoplasms 160

Interventions

Vinorelbine 1 Gemcitabine 1 Drug Therapy 1 Cisplatin 1 Cilengitide 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Metatropic dwarfism × Thoracic × Clear all

NCT00842712 2017-01-13

CERTO

Merck KGaA, Darmstadt, Germany

Phase 2 Completed

232 enrolled 17 charts

Metatropic dwarfism, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡